Skip to content
Unrated Drug recall · FDA · Published June 26, 2015

VistaPharm Recalls Metoclopramide Oral Solution Due to Defective Lids

VistaPharm recalls 84,100 cups of Metoclopramide Oral Solution because lids are not fully qualified. Check lot 387500.

🇺🇸 FDA recall #D-1831-2015DrugVistaPharm ›
Take action

Contact the company

Recalling firmVistaPharm, Inc.7265 Ulmerton Rd · Largo, FL 33771-4809
✎ GovInfoNow plain-language explainer

VistaPharm, Inc. is recalling Metoclopramide Oral Solution, USP 10 mg/10 mL sold in 10 mL cups. The recall is due to defective containers where the lids on the unit dose cups are not fully qualified. This issue affects a specific lot distributed across several U.S. states. Read more at govinfonow.com/recall/44125-vistapharm-inc-recalls-metoclopramide-oral-solution-usp-10-mg-10.

Source Summary by GovInfoNow · govinfonow.com/recall/44125-vistapharm-inc-recalls-metoclopramide-oral-solution-usp-10-mg-10 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1831-2015

Cite this page

“VistaPharm Recalls Metoclopramide Oral Solution Due to Defective Lids.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44125-vistapharm-inc-recalls-metoclopramide-oral-solution-usp-10-mg-10. Based on FDA recall #D-1831-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1831-2015%22&limit=1).

The FDA announced on June 26, 2015, that VistaPharm, Inc. voluntarily recalled Metoclopramide Oral Solution due to defective container lids that are not fully qualified. The recall affects 84,100 cups distributed in the U.S., including California, Illinois, Louisiana, Ohio, Pennsylvania, and South Carolina.

How to tell if you have it

  • Brand: VistaPharm
  • Product: Metoclopramide Oral Solution, USP 10 mg/10 mL
  • Form: 10 mL cups, Rx only
  • NDC: 66689-031-01
  • Lot #: 387500
  • Expiry: 01/17

The hazard

The hazard involves defective containers where lids on unit dose cups are not fully qualified. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show VistaPharm, Inc. has 19 other recalls on record since January 19, 2011. Other recent recalls of similar products include VistaPharm Pyridostigmine Bromide Oral Solution (September 30, 2022), VistaPharm Clobazam Oral Suspension (January 7, 2022), and VistaPharm NYSTATIN Oral Suspension (September 25, 2020). Other recent recalls of similar products include ANI Pharmaceuticals Estradiol Gel (May 12, 2026), Golden State Medical Prasugrel HCl 10mg Tablets (August 21, 2026), and Micro Labs Dorzolamide/Timolol Eye Drops (July 22, 2026).

How to tell if you have this one

Look for Metoclopramide Oral Solution, USP 10 mg/10 mL in 10 mL cups manufactured by VistaPharm, Inc. Check if the lot number is 387500 and the expiry date is 01/17. The NDC is 66689-031-01.

  • Brand
    VistaPharm
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed in 6 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: yesPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: yesSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: yesLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “U.S. Including: CA, IL, LA, OH, PA, and SC.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Illinois, Louisiana, Ohio, Pennsylvania, South Carolina.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Jun 26, 201512. FDA classified it Class III: Sep 28, 201523. Published in FDA’s Enforcement Report: Oct 7, 201534. FDA terminated the recall: Feb 14, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1831-2015 (June 26, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1831-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA